Research suggests that active surveillance is a safe and effective strategy for appropriately selected patients. By closely monitoring the cancer, doctors can intervene with curative therapies if and when necessary. This approach also mitigates potential harms such as surgical complications or radiation-related adverse events. However, not all prostate cancers are suitable candidates for active surveillance, so individualized patient assessment is crucial. By exploring the underlying research and consulting healthcare professionals, individuals can make informed decisions regarding their prostate cancer treatment options.
Over the last decade, more and more Americans with early-stage prostate cancer have put off radiation and surgery, the standard treatment options, new research indicates.Instead, many U.S. men with low- or intermediate-risk prostate cancer have embraced “active…